Press release
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and Sponsor Strategies
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from therapies that can ease the physical, psychological and emotional burden of cancer.A number of factors are changing the way market participants view the cancer therapeutics market. These factors are evident in the disease targets and drug classes that comprise a significant number of recent trials. After decades of disappointment and missed financial objectives, the genetic underpinnings of disease are converging with improved computer-assisted pharmacological decision making. Market sector participants now find themselves pursuing realistic therapeutic strategies that have the potential to fulfill product strategies in both scientific and human terms.
As immunotherapeutics in general – and immuno-oncology in particular - move to the forefront, the major oncology drug developers are beginning to align with specific therapeutic approaches, such as PARP and PD-1/PD-L1. Our analytics analysis of current active oncology trial data reveals these factors and how they are affecting the oncology drug development landscape.
By combining data on the oncology therapeutics landscape with the relational power of analytics we’ve created a unique information resource that provides insight and clarity on market sector activity and competitive positioning within the oncology therapeutics space. By grouping and formatting information into visualizations that are easy to digest, readers gain a new and revealing perspective on the oncology drug development market.
These developments are detailed in a new and comprehensive report researched and written by Greystone Research Associates. The report - Oncology Pipeline Analytics – Trials, Drug Classes, Correlations, Indications and Strategies - analyzes oncology drug development activity, commercial strategies, and therapeutic alignment. The report allows readers to pull back the curtain and evaluate the relative clinical developments, strategies and market positions of oncology drug developers. It includes analysis of treatment grouping by developer, indication, drug class, and development phase, activity profiles by developer and disease segment, development activity by company and therapeutic vector, and market statistics.
More information is available at http://www.greystoneassociates.org
Source: Greystone Research Associates
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
www.greystoneassociates.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and Sponsor Strategies here
News-ID: 1451596 • Views: …
More Releases from Greystone Research Associates
Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration…
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors.
A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when…
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population.
To fully address the unmet need these technologies…
For Injectable Drugs Wireless Connectivity Allows Caregivers to Manage Patients …
(Amherst, NH) – The growing emphasis on drug self-administration is having a major impact on the pharmaceutical industry. The aging population and managed care initiatives are major forces driving the growth of home healthcare, a trend that includes the self-administration of drug therapies for chronic conditions such as diabetes, arthritis and hormone replacement therapy. This trend is creating an increased demand for medical devices that are patient-friendly and cost-effective.
Much…
More Releases for Amherst
Cleanway Cleaning & Restoration Reaffirm Position as a Leading Air Duct Cleaning …
The family-owned company continues to provide clients in New York with top-of-the-line air duct cleaning and maintenance at very competitive rates
Indoor air quality is crucial for ensuring a healthy and comfortable living environment. Workplaces also require professional cleaning services to keep the working environment safe for staff members. This is why Cleanway Cleaning & Restoration [https://nycleanway.com/] has continued to provide top-notch cleaning solutions for both families and businesses geared toward…
Cleanway Cleaning & Restoration: Air Duct Cleaning in Amherst New York
Cleanway Cleaning & Restoration, a locally owned and operated business, Leading the way in Eco Friendly Cleaning Solutions for over 30 years of dedicated service to Amherst New York. With a steadfast commitment to environmental responsibility and customer satisfaction, Cleanway Cleaning & Restoration has become the top-rated choice for air duct cleaning and a variety of other professional cleaning services in the region.
Image: https://lh7-us.googleusercontent.com/rUl8c6J_MZJLi8jbUc0Vp5sONLDylIPfmva1UhD8I4Tffg2xULMk5yzTv9E97_OTsqA6_-FWazDNjDfTp79FnPJTyDaWQiWG4xfnXdOS5usg8EFaNxxF2ljCoiU1mebsmcfnbCmFyYxREK4jybVeMP0
Since its inception in 1989, Cleanway Cleaning…
Stunning Growth Report On Crop Nutrient Management Market 2023 with Key Players …
The Crop Nutrient Management market 2023 research report provides comprehensive information on the market. It also includes in-depth information about market drivers, opportunities, industry restraints and growth with challenges, and cumulative growth analysis. Moreover, the report also provides an in-depth analysis of the Crop Nutrient Management market by identifying key players. The report also examines the competitive landscape of the Crop Nutrient Management Market industry and analyses its impact on…
Future Growth : Crop Nutrient Management Market Sees Promising Growth in 2022 SM …
Worldwide Market Reports has added a new research study on Global "Crop Nutrient Management Market" 2022 by Size, Growth, Trends, and dynamics, Forecast to 2028 which is a result of an extensive examination of the market patterns. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of…
New Aircraft Designs Creating Opportunities for High Performance Aerospace Coati …
(Amherst, NH) – As aerospace manufacturers and their engineering teams push the design envelope to create aircraft with better fuel efficiency and lower maintenance requirements, they are relying increasingly on engineered materials for a growing list of structural and non-structural elements and components. This trend is changing the way aircraft are developed, produced and maintained. It’s also presenting opportunities for specialty materials suppliers with products that can improve production…
Evolution in Markets for Radiation Curable Coatings Creating Risks and Opportuni …
(Amherst, NH) – Recent advances in materials and equipment are creating new demand for radiation curable coatings in a number of industrial applications. This new demand is occurring as several technology advances are being brought into the marketplace. By removing some of the key limitations of radcure coatings, these advances are enabling radcure coatings to meet unique application requirements, opening up a number of new opportunities.
Technical advances that are having…
